English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Use of patient-derived tumor organoid platform to predict the benefit of postoperative adjuvant chemotherapy for poor responders to neoadjuvant chemoradiotherapy in locally advanced rectal cancer Journal article
Xue, Weisong, Wang, Ting, Yao, Jiaxin, Wu, Wei, Chen, Dexin, Yan, Botao, Dong, Xiaoyu, Tang, Yuting, Zeng, Yunli, He, Yueyu, Cao, Peihua, Shao, Fangyuan, Huang, Wenhua, Deng, Chuxia, Yan, Jun. Use of patient-derived tumor organoid platform to predict the benefit of postoperative adjuvant chemotherapy for poor responders to neoadjuvant chemoradiotherapy in locally advanced rectal cancer[J]. Bioengineering and Translational Medicine, 2023, 8(6), e10586.
Authors:  Xue, Weisong;  Wang, Ting;  Yao, Jiaxin;  Wu, Wei;  Chen, Dexin; et al.
Favorite | TC[WOS]:4 TC[Scopus]:3  IF:6.1/7.2 | Submit date：2023/12/04
Adjuvant Chemotherapy  Neoadjuvant Chemoradiotherapy  Nomogram  Organoid  Rectal Cancer  
Cutoff value of IC50 for drug sensitivity in patient-derived tumor organoids in colorectal cancer Journal article
Tang, Yuting, Wang, Ting, Hu, Yaowen, Ji, Hongli, Yan, Botao, Hu, Xiarong, Zeng, Yunli, Hao, Yifan, Xue, Weisong, Chen, Zexin, Lan, Jianqiang, Wang, Yanan, Deng, Haijun, Deng, Chuxia, Wu, Xiufeng, Yan, Jun. Cutoff value of IC50 for drug sensitivity in patient-derived tumor organoids in colorectal cancer[J]. iScience, 2023, 26(7).
Authors:  Tang, Yuting;  Wang, Ting;  Hu, Yaowen;  Ji, Hongli;  Yan, Botao; et al.
Favorite | TC[WOS]:5 TC[Scopus]:6  IF:4.6/5.0 | Submit date：2024/01/02
Patient-Derived Tumor Organoids Can Predict the Progression-Free Survival of Patients with Stage IV Colorectal Cancer after Surgery Journal article
Wang, Ting, Tang, Yuting, Pan, Wenjun, Yan, Botao, Hao, Yifan, Zeng, Yunli, Chen, Zexin, Lan, Jianqiang, Zhao, Shuhan, Deng, Chuxia, Zheng, Hang, Yan, Jun. Patient-Derived Tumor Organoids Can Predict the Progression-Free Survival of Patients with Stage IV Colorectal Cancer after Surgery[J]. Diseases of the Colon and Rectum, 2023, 66(5), 733-743.
Authors:  Wang, Ting;  Tang, Yuting;  Pan, Wenjun;  Yan, Botao;  Hao, Yifan; et al.
Favorite | TC[WOS]:10 TC[Scopus]:10  IF:3.2/4.0 | Submit date：2023/06/05
Drug Tests  Patient-derived Tumor Organoid  Predictive Model  Prognostic Value  Progression-free Survival  Stage Iv Colorectal Cancer